| Other names |
PDE V, cGMP-specific PDE |
HCP1 |
– |
High-affinity cAMP- specific and IBMX- insensitive PDE |
– |
| Ensembl ID |
ENSG00000138735 |
ENSG00000104732 |
ENSG00000171408 |
ENSG00000073417 |
ENSG00000113231 |
| Rank order of affinity |
cGMP > cAMP |
cAMP >> cGMP (Michaeli et al., 1993) |
cAMP >> cGMP (Gardner et al., 2000) |
cAMP >> cGMP (Fisher et al., 1998a) |
cAMP >> cGMP (Hayashi et al., 1998) |
| Activators |
PKA (Corbin et al., 2000), PKG (Corbin et al., 2000) |
– |
– |
– |
– |
| Selective inhibitors |
T0156 (9.5, Mochida et al., 2002), sildenafil (9.0, Turko et al., 1999), SCH51866 (7.2, Vemulapalli et al., 1996), zaprinast (6.8, Turko et al., 1999) |
BRL50481 (6.7, Smith et al., 2004) |
Dipyridamole (5.7–6.0, Gardner et al., 2000); Sasaki et al., 2000), SCH51866 (5.8, Sasaki et al., 2000) |
Dipyridamole (5.1, Fisher et al., 1998a) |
Dipyridamole (4.3, Hayashi et al., 1998) |